Invesco Pharmaceuticals ETF Rating $82.13 -0.99 (-1.19%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Invesco Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PJP Aggregate RatingModerate Buy 2.68Holdings in PJP have an aggregate rating of Moderate Buy based on 345 analyst ratings issued in the past year covering 25 companies (88.0% of the portfolio).PJP Aggregate Price Target$82.180.06% UpsideHigh Prediction$82.18Average Prediction$82.18Low Prediction$82.18Holdings in PJP have an aggregate price target of $82.18 and a range of $82.18 to $82.18 covering 25 companies (88.0% of the portfolio).PJP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy9 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 PJP Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.19%LLYEli Lilly and Company$771.78+1.3%4.979 of 5 stars2.75$1,012.56 31.2%20Trending News5.18%PFEPfizer$24.46-0.5%4.9633 of 5 stars2.45$28.55 16.7%22Trending News5.16%MRKMerck & Co., Inc.$79.97-1.9%4.9955 of 5 stars2.43$108.69 35.9%21Positive News5.08%AMGNAmgen$294.76-1.2%4.4119 of 5 stars2.35$307.82 4.4%23Trending NewsAnalyst Revision4.97%GILDGilead Sciences$108.22-0.5%4.893 of 5 stars2.77$111.38 2.9%26Trending NewsInsider TradeAnalyst Revision4.91%ABBVAbbVie$189.26-1.1%4.7838 of 5 stars2.81$211.29 11.6%27Trending NewsEx-DividendAnalyst Revision4.88%JNJJohnson & Johnson$163.65+0.4%4.7808 of 5 stars2.57$172.87 5.6%21Trending NewsEarnings ReportDividend AnnouncementAnalyst ForecastOptions VolumeAnalyst Revision4.80%ABTAbbott Laboratories$123.81+2.7%4.988 of 5 stars2.82$144.47 16.7%22Trending NewsEarnings ReportEx-DividendAnalyst ForecastHigh Trading Volume4.05%OCULOcular Therapeutix$11.33-0.4%3.9284 of 5 stars3.00$17.33 53.0%6Positive News3.14%LGNDLigand Pharmaceuticals$139.10+1.1%3.5289 of 5 stars3.00$147.17 5.8%6High Trading Volume2.98%AMRXAmneal Pharmaceuticals$7.97-3.3%3.2298 of 5 stars3.00$11.60 45.5%5News Coverage2.92%ANIPANI Pharmaceuticals$66.30-2.6%3.7695 of 5 stars3.00$78.88 19.0%92.87%COLLCollegium Pharmaceutical$31.20-3.3%4.4187 of 5 stars2.75$43.75 40.2%4Positive News2.80%VTRSViatris$8.88-4.2%3.2614 of 5 stars1.80$10.40 17.1%5Trending News2.78%TVTXTravere Therapeutics$16.11-2.4%3.7283 of 5 stars2.87$32.14 99.5%15News CoverageAnalyst Revision2.75%AVDLAvadel Pharmaceuticals$10.83-0.1%1.847 of 5 stars3.00$18.33 69.3%6Analyst Forecast2.70%BIIBBiogen$124.99-2.9%4.9139 of 5 stars2.38$188.48 50.8%32Trending NewsInsider TradeAnalyst Revision2.66%JAZZJazz Pharmaceuticals$112.87-1.7%4.8116 of 5 stars2.93$181.71 61.0%14Analyst Forecast2.65%BMYBristol Myers Squibb$47.40-1.4%4.8945 of 5 stars2.32$57.69 21.7%22Trending NewsAnalyst Revision2.65%HRMYHarmony Biosciences$35.20-3.4%4.8037 of 5 stars3.00$51.33 45.8%9Positive News2.62%SUPNSupernus Pharmaceuticals$32.34-3.7%2.3694 of 5 stars2.33$36.00 11.3%3Positive News2.61%INVAInnoviva$19.57-1.6%4.0828 of 5 stars3.00$40.33 106.1%3Analyst Revision2.60%PRGOPerrigo$26.95-0.7%4.6253 of 5 stars2.25$33.00 22.4%4News CoveragePositive News2.57%TARSTarsus Pharmaceuticals$43.25+4.5%1.7735 of 5 stars3.00$66.67 54.1%7News CoverageAnalyst RevisionGap Up2.49%UTHRUnited Therapeutics$292.01-1.8%4.9865 of 5 stars2.69$383.08 31.2%13Positive News This page (NYSEARCA:PJP) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredFREE BUY ALERT: These 3 tiny AI stocks could surgeWe're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | SponsoredWill I be blacklisted?Porter Stansberry says a financial force bigger than 9/11 or COVID is already ripping through America — and mo...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PJP Stock Alerts